Market Lupin launches generic hypertension drug in US after regulatory nod By: admin Date: June 21, 2026 Lupin has launched Azilsartan Medoxomil tablets in the US after securing FDA approval, becoming the exclusive first-to-file generic applicant and gaining 180 days of market exclusivity for the hypertension treatment. 2 Min Read Continue Reading (Edited by : Sheersh Kapoor) Source link Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on WhatsApp (Opens in new window) WhatsApp Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on X (Opens in new window) X Click to share on Telegram (Opens in new window) Telegram Click to share on X (Opens in new window) X Like this:Like Loading... Related TagsdruggenericHypertensionlaunchesLupinnodregulatory Previous articleBuy or sell: Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday – 22 June 2026Next articleDalal Street Week Ahead: Lower volatility signals calm, but resistance looms large admin LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Share post: FacebookTwitterPinterestWhatsApp SubscribeI want inI've read and accept the Privacy Policy. Popular India’s differences with US must be managed through firm negotiation, says Global Trade Research Institute BRICS Trade Ministers meet agrees to close global trade finance gap of $2.5 trillion for MSMEs PFRDA aims to raise non-govt NPS subscriber base to 35-40 crore in 5 years Goldman Sachs, CLSA split on RBI rate outlook as inflation, growth debate heats up BRICS nations adopt joint declaration as India hosts industry ministers’ meet in Jaipur More like thisRelated India’s differences with US must be managed through firm negotiation, says Global Trade Research Institute admin - August 8, 2026 The US Senate has overwhelmingly approved legislation that could... BRICS Trade Ministers meet agrees to close global trade finance gap of $2.5 trillion for MSMEs admin - August 8, 2026 The 16th BRICS Trade Ministers' Meeting 2026 concluded in... PFRDA aims to raise non-govt NPS subscriber base to 35-40 crore in 5 years admin - August 8, 2026 Pension Fund Regulatory and Development Authority (PFRDA) on Friday... Goldman Sachs, CLSA split on RBI rate outlook as inflation, growth debate heats up admin - August 7, 2026 Goldman Sachs Chief India Economist Santanu Sengupta and CLSA...